Liquidia wins against United Therapeutics in patent battle over PAH drug
United Therapeutics has suffered two court losses in its fight to keep a competitor for its blockbuster drug Tyvaso (treprostinil) from entering the market, with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.